Hemostemix Inc (HEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.839x

Based on the latest financial reports, Hemostemix Inc (HEM) has a cash flow conversion efficiency ratio of 0.839x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-2.91 Million ≈ $-2.10 Million USD) by net assets (CA$-3.46 Million ≈ $-2.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hemostemix Inc (HEM) liquidity interval to measure how many days the company can operate on defensive assets alone.

Hemostemix Inc - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Hemostemix Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Hemostemix Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hemostemix Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Damodar Industries Limited NSE:DAMODARIND	0.146x
Morella Corporation Ltd AU:1MC	-0.082x
Redsense Medical AB ST:REDS	-0.053x
PharmaCyte Biotech Inc NASDAQ:PMCB	-0.020x
JPMorgan Euro Small Companies Trust Plc LSE:JEDT	0.026x
Lekoil Limited F:L5K	0.029x
Hanil Vacuum Co. Ltd KQ:123840	-0.052x
Straits Inter Logistics Bhd KLSE:0080	0.211x

Annual Cash Flow Conversion Efficiency for Hemostemix Inc (2013–2024)

The table below shows the annual cash flow conversion efficiency of Hemostemix Inc from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Hemostemix Inc market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-7.20 Million ≈ $-5.21 Million	CA$-1.90 Million ≈ $-1.38 Million	0.264x	+29.94%
2023-12-31	CA$-7.37 Million ≈ $-5.33 Million	CA$-1.50 Million ≈ $-1.08 Million	0.203x	-77.46%
2022-12-31	CA$-6.77 Million ≈ $-4.90 Million	CA$-6.10 Million ≈ $-4.41 Million	0.901x	+36.96%
2021-12-31	CA$-5.28 Million ≈ $-3.82 Million	CA$-3.48 Million ≈ $-2.52 Million	0.658x	-87.90%
2020-12-31	CA$-1.10 Million ≈ $-794.78K	CA$-5.98 Million ≈ $-4.32 Million	5.438x	+546.31%
2019-12-31	CA$-4.05 Million ≈ $-2.93 Million	CA$-3.40 Million ≈ $-2.46 Million	0.841x	+115.26%
2018-12-31	CA$487.80K ≈ $352.87K	CA$-2.69 Million ≈ $-1.95 Million	-5.513x	-730.03%
2017-12-31	CA$4.84 Million ≈ $3.50 Million	CA$-3.21 Million ≈ $-2.32 Million	-0.664x	-185.48%
2016-12-31	CA$-3.46 Million ≈ $-2.50 Million	CA$-2.69 Million ≈ $-1.95 Million	0.777x	+103.82%
2015-12-31	CA$174.08K ≈ $125.93K	CA$-3.55 Million ≈ $-2.56 Million	-20.365x	-2102.29%
2014-12-31	CA$3.39 Million ≈ $2.45 Million	CA$-3.13 Million ≈ $-2.27 Million	-0.925x	+52.07%
2013-12-31	CA$573.87K ≈ $415.13K	CA$-1.11 Million ≈ $-800.95K	-1.929x	--

About Hemostemix Inc

V:HEM Canada Biotechnology

Market Cap

$7.50 Million

CA$10.37 Million CAD

Market Cap Rank

#27722 Global

#1202 in Canada

Share Price

CA$0.06

Change (1 day)

+0.00%

52-Week Range

CA$0.05 - CA$0.15

All Time High

CA$13.40